PDT Partners’s PTC Therapeutics PTCT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.25M | Sell |
25,684
-14,651
| -36% | -$716K | 0.07% | 381 |
|
|
2025
Q1 | $2.06M | Sell |
40,335
-51,746
| -56% | -$2.64M | 0.15% | 244 |
|
|
2024
Q4 | $4.16M | Sell |
92,081
-72,987
| -44% | -$3.29M | 0.37% | 67 |
|
|
2024
Q3 | $6.12M | Buy |
165,068
+25,688
| +18% | +$953K | 0.54% | 12 |
|
|
2024
Q2 | $4.26M | Sell |
139,380
-35,859
| -20% | -$1.1M | 0.4% | 49 |
|
|
2024
Q1 | $5.1M | Sell |
175,239
-268
| -0.2% | -$7.8K | 0.48% | 30 |
|
|
2023
Q4 | $4.84M | Buy |
175,507
+111,112
| +173% | +$3.06M | 0.53% | 29 |
|
|
2023
Q3 | $1.44M | Buy |
64,395
+1,478
| +2% | +$33.1K | 0.18% | 186 |
|
|
2023
Q2 | $2.56M | Sell |
62,917
-47
| -0.1% | -$1.91K | 0.35% | 75 |
|
|
2023
Q1 | $3.05M | Buy |
62,964
+69
| +0.1% | +$3.34K | 0.41% | 74 |
|
|
2022
Q4 | $2.4M | Sell |
62,895
-7,684
| -11% | -$293K | 0.39% | 58 |
|
|
2022
Q3 | $3.54M | Sell |
70,579
-26,452
| -27% | -$1.33M | 0.54% | 7 |
|
|
2022
Q2 | $3.89M | Buy |
97,031
+3,062
| +3% | +$123K | 0.34% | 47 |
|
|
2022
Q1 | $3.51M | Buy |
+93,969
| New | +$3.51M | 0.3% | 73 |
|
|
2019
Q1 | – | Sell |
-277,609
| Closed | -$9.53M | – | 488 |
|
|
2018
Q4 | $9.53M | Sell |
277,609
-12
| -0% | -$412 | 0.53% | 48 |
|
|
2018
Q3 | $13M | Buy |
277,621
+20
| +0% | +$940 | 0.54% | 48 |
|
|
2018
Q2 | $9.36M | Buy |
277,601
+1
| +0% | +$34 | 0.36% | 98 |
|
|
2018
Q1 | $7.51M | Buy |
+277,600
| New | +$7.51M | 0.25% | 134 |
|
|
2017
Q1 | – | Sell |
-161,100
| Closed | -$1.76M | – | 522 |
|
|
2016
Q4 | $1.76M | Sell |
161,100
-5,000
| -3% | -$54.6K | 0.12% | 261 |
|
|
2016
Q3 | $2.33M | Buy |
+166,100
| New | +$2.33M | 0.14% | 205 |
|